All sites C00-96,D32-33,D42-43,D45-47,D76 2210 88.8 2.7 4.6 0.9 3.0
Mouth, pharynx C00-14 40 97.5 0.5 - - 2.0
  Lip C00 5 100.0 - - - -
  Tongue C02 10 98.0 - - - 2.0
  Mouth, other C03-06 15 97.3 - - - 2.7
  Salivary glands C07-08 5 92.6 3.7 - - 3.7
  Pharynx C01,C09-14 5 100.0 - - - -
Digestive organs C15-26 429 79.0 2.1 11.4 1.9 5.6
  Oesophagus C15 11 87.5 - 3.6 3.6 5.4
  Stomach C16 45 93.4 - 2.6 1.3 2.6
  Small intestine C17 8 92.5 - 5.0 - 2.5
  Colon C18 142 94.8 0.1 2.1 0.7 2.2
  Rectum, rectosigmoid C19-20 69 96.5 - 0.9 0.6 2.0
  Anus C21 4 100.0 - - - -
  Liver C22 27 64.2 2.9 24.8 1.5 6.6
  Gallbladder, bile ducts C23-24 25 55.3 9.8 21.1 0.8 13.0
  Pancreas C25 90 45.2 6.2 33.5 3.5 11.5
  Other digestive organs C26 7 26.5 2.9 14.7 26.5 29.4
Respiratory organs C30-39 105 66.4 13.3 12.5 2.1 5.7
  Nose, sinuses C30-31 2 100.0 - - - -
  Larynx, epiglottis C32 2 100.0 - - - -
  Lung, trachea C33-34 99 66.0 14.1 12.5 2.2 5.2
  Mediastinum, pleura C38 1 16.7 - 50.0 - 33.3
Bone C40-41 3 70.6 - 17.6 - 11.8
Melanoma of the skin C43 79 100.0 - - - -
Skin, non-melanoma C44 120 99.8 - - - 0.2
Mesothelioma C45 2 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 17 96.4 1.2 1.2 - 1.2
Breast C50 660 99.3 0.1 0.2 0.1 0.3
Female genital organs C51-58 275 94.5 2.2 1.7 0.6 1.0
  Cervix uteri C53 24 94.9 2.5 0.8 1.7 -
  Corpus uteri C54 140 98.7 0.1 0.3 0.3 0.6
  Uterus, other C55,C58 1 33.3 - 66.7 - -
  Ovary C56 78 87.1 6.2 4.6 0.3 1.8
  Other female genital C51-52,C57 33 94.5 1.2 0.6 1.8 1.8
Urinary organs C64-68 102 90.6 0.4 5.5 1.0 2.5
  Kidney C64 61 87.8 0.3 8.3 1.3 2.3
  Bladder and urinary tract2 C65-68 42 94.7 0.5 1.4 0.5 2.9
Eye C69 4 63.2 - 21.1 10.5 5.3
Brain, central nervous system C70-72,D32-33,D42-43 80 84.0 - 10.3 1.3 4.5
Thyroid gland C73 46 98.3 0.4 - 0.9 0.4
Other endocrine glands C74-75 2 75.0 - 25.0 - -
Illdefined or unknown C76,C80 53 48.5 13.3 25.4 2.3 10.6
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 191 75.6 11.2 2.6 1.7 8.9
  Hodgkin lymphoma C81 10 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 92 98.7 0.2 - - 1.1
  Malignant immunoproliferative diseases C88 1 100.0 - - - -
  Myeloma and other plasma cell tumors C90 27 44.0 19.4 18.7 5.2 12.7
  Leukaemia C91-95 36 51.1 29.2 - 3.4 16.3
  Myelodysplastic syndromes D46 8 27.5 17.5 - 2.5 52.5
  Myeloproliferaitive neoplasms D45,D47 17 58.6 24.1 - 2.3 14.9
Not included above
  Carcinoma in situ of the breast D05 43 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 86 100.0 - - - -
  Borderline tumour of the ovary D39 33 97.6 - - - 2.4
  Basal cell carcinoma of the skin 848 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.